enkephalin, leucine and mazindol

enkephalin, leucine has been researched along with mazindol in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jenner, P; Jolkkonen, J; Marsden, CD1
Broide, RS; Leslie, FM; Loughlin, SE; Smith, JA1
Brotchie, JM; Crossman, AR; Henry, B1
Decamp, E; Schneider, JS; Wade, T1
Cannizzaro, C; Costa, S; Iravani, MM; Jackson, MJ; Jenner, P; Pearce, RK; Tel, BC1
Cannizzaro, C; Jenner, P; Pearce, RK; Rose, S; Tel, BC; Zeng, BY1
Amalric, M; Breysse, N; Kerkerian-Le Goff, L; Oueslati, A; Salin, P1

Other Studies

7 other study(ies) available for enkephalin, leucine and mazindol

ArticleYear
L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.
    Brain research. Molecular brain research, 1995, Volume: 32, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Callithrix; Caudate Nucleus; Enkephalins; Female; Gene Expression; In Situ Hybridization; Levodopa; Male; Mazindol; Motor Activity; Nucleus Accumbens; Putamen; RNA, Messenger; Substance P

1995
Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
    Neuroscience, 1993, Volume: 55, Issue:4

    Topics: Animals; Corpus Striatum; Dopamine; Down-Regulation; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Gene Expression Regulation; Male; Mazindol; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Opioid; RNA, Messenger; Substantia Nigra; Time Factors

1993
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Experimental neurology, 1999, Volume: 155, Issue:2

    Topics: Animals; Autoradiography; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Enkephalins; In Situ Hybridization; Levodopa; Lisuride; Male; Mazindol; Medial Forebrain Bundle; Neostriatum; Oligonucleotide Probes; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Radioligand Assay; Rats; Rats, Sprague-Dawley; RNA, Messenger

1999
Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999, Aug-01, Volume: 19, Issue:15

    Topics: Acute Disease; Animals; Autoradiography; Behavior, Animal; Chronic Disease; Corpus Striatum; Enkephalins; Gene Expression Regulation; Globus Pallidus; In Situ Hybridization; Macaca fascicularis; Male; Mazindol; Neural Pathways; Parkinson Disease, Secondary; Protein Precursors

1999
GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.
    The European journal of neuroscience, 2001, Volume: 13, Issue:3

    Topics: Animals; Antiparkinson Agents; Body Weight; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Gene Expression; Glial Cell Line-Derived Neurotrophic Factor; Levodopa; Locomotion; Male; Mazindol; MPTP Poisoning; Nerve Growth Factors; Nerve Tissue Proteins; Neuroprotective Agents; Protein Precursors; Recovery of Function; RNA, Messenger; Substantia Nigra; Tachykinins; Tritium; Tyrosine 3-Monooxygenase

2001
Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.
    Neuroscience, 2002, Volume: 115, Issue:4

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Male; Mazindol; Neostriatum; Neural Pathways; Neuropeptides; Parkinsonian Disorders; Protein Precursors; Receptors, Purinergic P1; RNA, Messenger; Tachykinins

2002
Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
    The European journal of neuroscience, 2005, Volume: 22, Issue:11

    Topics: Animals; Basal Ganglia; Cerebral Cortex; Denervation; Dopamine Uptake Inhibitors; Electron Transport Complex IV; Enkephalins; Excitatory Amino Acid Antagonists; In Situ Hybridization; Male; Mazindol; Neostriatum; Nerve Net; Neurons; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Rats; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; RNA, Messenger; Sympatholytics; Tachykinins; Thalamus

2005